PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

44,493 stories, page 597 of 742

Advanced search
🌍Researchdoi.orgTier 1 · Research record

Optimizing integrated multienzyme‐membrane system to maximize xylo‐oligosaccharide yield and eradicate inhibitors: addressing fouling and sugar purification in pineapple residue processing

CrossrefOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07684950: Lisaftoclax Plus Pirtobrutinib in Relapsed or Refractory Mantle Cell Lymphoma After BTK-Targeted Therapy

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07684677: Effect of Participating in a Study of Causes of Pregnancy Loss on Mental Health Outcomes: A Target Trial Emulation Using the COPL Cohort and Danish National Registries

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07684560: Phase Ib, Randomized, Double-blind, Placebo-Controlled, Dose-Escalation Study of Alpha-0261 Tablets to Assess Safety and Tolerability in Patients With Chronic Spontaneous Urcaria (Part 1) and Food Effect in Healthy Adults (Part 2).

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07684456: Efficacy and Safety of Utidelone Capsule and Utidelone Injection in Patients With HER-2 Negative Advanced Breast Cancer

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07684144: Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07683377: Safety and Efficacy Analysis of Stent-assisted Coil Embolization in the Treatment of Acute Ruptured Intracranial Aneurysms in the Perioperative Period.

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07683299: HEMO-INTEGRA: Integrated Intraoperative Hemodynamic Monitoring During Cardiac Surgery With Cardiopulmonary Bypass - A Pilot Study

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07682792: Golidocitinib in Patients With Mycosis Fungoides/Sézary Syndrome and T-Cell Large Granular Lymphocytic Leukemia

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07601113: PG2 Breast Cancer Evaluation in Adjuvant Medicine-Survival Study

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07447128: Prospective Analysis of Arteriovenous Access (AVA) Use in Continuous Renal Replacement Therapy: A Feasibility Project

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07264114: Aquatic High-Intensity Interval Training for Parkinson's Disease

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07174310: A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07082998: Comparing the Efficacy of Heated Yoga and Sauna as a Treatment for Depression

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07082049: AI-LLM Communication Aid in Prostate Cancer Care (AI-CAP）

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06834152: Online Adaptive Stereotactic Body Radiotherapy for Localized Prostate Cancer

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06663319: A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06627413: Safety, Tolerability, and Pharmacokinetics of Lumateperone Long-Acting Injectable Formulations in Patients With Schizophrenia or Schizoaffective Disorder

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06441266: M-PART in Head and Neck Cancer Patients Treated With KeraStat Cream for Acute Radiation Dermatitis

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05957276: Global Patient Registry of Inherited Retinal Diseases

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05870579: [177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05138848: Time-in-bed Restriction in Older Adults With Sleep Difficulties With and Without Risk for Alzheimer's Disease

Study type: INTERVENTIONAL. Phase: EARLY_PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT04722146: A Study of Teclistamab With Other Anticancer Therapies in Participants With Multiple Myeloma

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT04609566: Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT04084678: Study of Ralinepag on Exercise Capacity by Cardiopulmonary Exercise Testing (CPET) in WHO Group 1 PH Subjects

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT03976843: Prostate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancer

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT03854552: A Study in Healthy Men Tests How Different Doses of BI 764198 Are Taken up in the Body and How Well They Are Tolerated.

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT03684278: Randomised Treatment of Acute Pancreatitis With Infliximab: Double-blind, Placebo-controlled, Multi-centre Trial (RAPID-I)

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT03533283: An Open-Label Phase lB/II Study of Glofitamab and Atezolizumab or Polatuzumab Vedotin in Adult Patients With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT03523442: A Study of Androgen Receptor (AR) Antagonist Apalutamide in Chinese Participants With Metastatic Castration-Resistant Prostate Cancer

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT03130244: Procedure for Duodenum to Ileal Diversion to Treat Type 2 Diabetes

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT02531516: An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT02123758: A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

iX BIOPHARMA: Will These Upcoming Milestones Re-rate The Stock?

NextInsightOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

ABVX Stock Rockets 28% After Abivax Eases Drug Safety Concerns With Fresh Clinical Data

StocktwitsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

United Parcel Service, Inc. (UPS) Eyes Medicines and Pharmaceutical Opportunities with $48M Investment

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Editorial | Independent drug approvals are key to Hong Kong’s biotech ambitions

South China Morning PostOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Does CRISPR Therapeutics’ (CRSP) Russell Index Debut Quietly Reframe Its Biotech Growth Narrative?

simplywall.stOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biotech ETF (BBC) touches a new 52-week high

MSNOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The Hidden Reason Biotech Breakthroughs Keep Getting Delayed

inc.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Texas Biomed teams up with UK-based biotech company to fight screwworm

San Antonio ReportOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Phase 3 SIGMA Trial of Safusidenib Is Initiated for IDH1-Mutant Glioma

Targeted OncologyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Roche collaborates with Nurix Therapeutics to develop BTK degrader bexobrutideg for cancer and immune diseases

Select ScienceOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Lung-Focused Celea Secures $180M for Pivotal Test of Pulmonary Fibrosis Drug

MedCity NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

MEPs supportive of draft Biotech report, but divisions over incentives remain

EU ReporterOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

IHE vs. PJP: Which Pharmaceutical ETF Is the Better Buy for Investors?

The Motley FoolOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Viatris Inc. is One of the 10 Most Undervalued NASDAQ Stocks to Buy Right Now

sekbernews.idOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biotech Stocks Are Surging in 2026. This One Stands Out After a Pullback.

TheStreet ProOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to sales forward of Collegium Pharmaceutical, Inc. – FWB:354

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to book forward of China Resources Jiangzhong Pharmaceutical Co., Ltd. Class A – SSE:600750

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Roche Reports Positive Phase 3 Results for Divarasib in Previously Treated KRAS G12C NSCLC

OncodailyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to earnings forward of CTT Pharmaceutical Holdings, Inc. – OTC:CTTH

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA Flags Three Beauty Creams Over Toxic Mercury and Lead Levels

BizzBuzzOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA warns against three beauty creams after tests detect excessive mercury, lead levels

The Hans IndiaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Fidelity Health Care vs. State Street Biotech: Which ETF Fits Your Portfolio Best?

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

GNI Group Acquires Ayumi Pharmaceutical For JPY 44.8 Billion (About $276 Million)

Pulse 2.0Original source
🌍discoverynews.google.comTier 3 · Aggregated media

Viatris (VTRS): Most Undervalued NASDAQ Stocks to Buy Right Now

Insider MonkeyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Viatris (VTRS): Most Undervalued NASDAQ Stocks to Buy Right Now

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

AI Is Transforming Drug Discovery. Here Is the Next Trillion-Dollar Biotech Opportunity

AOL.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

883035 Forecast — Price Target — Prediction for 2027

TradingViewOriginal source